nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—Conjunctivitis—Doxorubicin—testicular cancer	0.000306	0.000306	CcSEcCtD
Ropinirole—Haemorrhage—Epirubicin—testicular cancer	0.000306	0.000306	CcSEcCtD
Ropinirole—Eye disorder—Methotrexate—testicular cancer	0.000305	0.000305	CcSEcCtD
Ropinirole—Tinnitus—Methotrexate—testicular cancer	0.000305	0.000305	CcSEcCtD
Ropinirole—Hypoaesthesia—Epirubicin—testicular cancer	0.000304	0.000304	CcSEcCtD
Ropinirole—Asthenia—Cisplatin—testicular cancer	0.000304	0.000304	CcSEcCtD
Ropinirole—Pharyngitis—Epirubicin—testicular cancer	0.000304	0.000304	CcSEcCtD
Ropinirole—Cardiac disorder—Methotrexate—testicular cancer	0.000303	0.000303	CcSEcCtD
Ropinirole—Urinary tract disorder—Epirubicin—testicular cancer	0.000302	0.000302	CcSEcCtD
Ropinirole—Oedema peripheral—Epirubicin—testicular cancer	0.000301	0.000301	CcSEcCtD
Ropinirole—Haematuria—Doxorubicin—testicular cancer	0.000301	0.000301	CcSEcCtD
Ropinirole—Connective tissue disorder—Epirubicin—testicular cancer	0.000301	0.000301	CcSEcCtD
Ropinirole—Urethral disorder—Epirubicin—testicular cancer	0.0003	0.0003	CcSEcCtD
Ropinirole—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000298	0.000298	CcSEcCtD
Ropinirole—Epistaxis—Doxorubicin—testicular cancer	0.000297	0.000297	CcSEcCtD
Ropinirole—Angiopathy—Methotrexate—testicular cancer	0.000297	0.000297	CcSEcCtD
Ropinirole—Sinusitis—Doxorubicin—testicular cancer	0.000296	0.000296	CcSEcCtD
Ropinirole—Immune system disorder—Methotrexate—testicular cancer	0.000295	0.000295	CcSEcCtD
Ropinirole—Visual impairment—Epirubicin—testicular cancer	0.000295	0.000295	CcSEcCtD
Ropinirole—Mediastinal disorder—Methotrexate—testicular cancer	0.000295	0.000295	CcSEcCtD
Ropinirole—Agranulocytosis—Doxorubicin—testicular cancer	0.000294	0.000294	CcSEcCtD
Ropinirole—Chills—Methotrexate—testicular cancer	0.000293	0.000293	CcSEcCtD
Ropinirole—Nausea—Ifosfamide—testicular cancer	0.000292	0.000292	CcSEcCtD
Ropinirole—Diarrhoea—Cisplatin—testicular cancer	0.00029	0.00029	CcSEcCtD
Ropinirole—Alopecia—Methotrexate—testicular cancer	0.000289	0.000289	CcSEcCtD
Ropinirole—Bradycardia—Doxorubicin—testicular cancer	0.000288	0.000288	CcSEcCtD
Ropinirole—Mental disorder—Methotrexate—testicular cancer	0.000286	0.000286	CcSEcCtD
Ropinirole—Eye disorder—Epirubicin—testicular cancer	0.000286	0.000286	CcSEcCtD
Ropinirole—Hypersensitivity—Etoposide—testicular cancer	0.000286	0.000286	CcSEcCtD
Ropinirole—Tinnitus—Epirubicin—testicular cancer	0.000285	0.000285	CcSEcCtD
Ropinirole—Malnutrition—Methotrexate—testicular cancer	0.000284	0.000284	CcSEcCtD
Ropinirole—Haemoglobin—Doxorubicin—testicular cancer	0.000284	0.000284	CcSEcCtD
Ropinirole—Flushing—Epirubicin—testicular cancer	0.000284	0.000284	CcSEcCtD
Ropinirole—Cardiac disorder—Epirubicin—testicular cancer	0.000284	0.000284	CcSEcCtD
Ropinirole—Rhinitis—Doxorubicin—testicular cancer	0.000284	0.000284	CcSEcCtD
Ropinirole—Haemorrhage—Doxorubicin—testicular cancer	0.000283	0.000283	CcSEcCtD
Ropinirole—Hypoaesthesia—Doxorubicin—testicular cancer	0.000282	0.000282	CcSEcCtD
Ropinirole—Pharyngitis—Doxorubicin—testicular cancer	0.000281	0.000281	CcSEcCtD
Ropinirole—Urinary tract disorder—Doxorubicin—testicular cancer	0.000279	0.000279	CcSEcCtD
Ropinirole—Oedema peripheral—Doxorubicin—testicular cancer	0.000279	0.000279	CcSEcCtD
Ropinirole—Dysgeusia—Methotrexate—testicular cancer	0.000279	0.000279	CcSEcCtD
Ropinirole—Asthenia—Etoposide—testicular cancer	0.000278	0.000278	CcSEcCtD
Ropinirole—Connective tissue disorder—Doxorubicin—testicular cancer	0.000278	0.000278	CcSEcCtD
Ropinirole—Angiopathy—Epirubicin—testicular cancer	0.000277	0.000277	CcSEcCtD
Ropinirole—Urethral disorder—Doxorubicin—testicular cancer	0.000277	0.000277	CcSEcCtD
Ropinirole—Immune system disorder—Epirubicin—testicular cancer	0.000276	0.000276	CcSEcCtD
Ropinirole—Mediastinal disorder—Epirubicin—testicular cancer	0.000276	0.000276	CcSEcCtD
Ropinirole—Back pain—Methotrexate—testicular cancer	0.000275	0.000275	CcSEcCtD
Ropinirole—Chills—Epirubicin—testicular cancer	0.000274	0.000274	CcSEcCtD
Ropinirole—Pruritus—Etoposide—testicular cancer	0.000274	0.000274	CcSEcCtD
Ropinirole—Arrhythmia—Epirubicin—testicular cancer	0.000273	0.000273	CcSEcCtD
Ropinirole—Visual impairment—Doxorubicin—testicular cancer	0.000273	0.000273	CcSEcCtD
Ropinirole—Alopecia—Epirubicin—testicular cancer	0.00027	0.00027	CcSEcCtD
Ropinirole—Vomiting—Cisplatin—testicular cancer	0.000269	0.000269	CcSEcCtD
Ropinirole—Vision blurred—Methotrexate—testicular cancer	0.000268	0.000268	CcSEcCtD
Ropinirole—Mental disorder—Epirubicin—testicular cancer	0.000268	0.000268	CcSEcCtD
Ropinirole—Rash—Cisplatin—testicular cancer	0.000267	0.000267	CcSEcCtD
Ropinirole—Dermatitis—Cisplatin—testicular cancer	0.000267	0.000267	CcSEcCtD
Ropinirole—Malnutrition—Epirubicin—testicular cancer	0.000266	0.000266	CcSEcCtD
Ropinirole—Diarrhoea—Etoposide—testicular cancer	0.000265	0.000265	CcSEcCtD
Ropinirole—Eye disorder—Doxorubicin—testicular cancer	0.000264	0.000264	CcSEcCtD
Ropinirole—Ill-defined disorder—Methotrexate—testicular cancer	0.000264	0.000264	CcSEcCtD
Ropinirole—Tinnitus—Doxorubicin—testicular cancer	0.000264	0.000264	CcSEcCtD
Ropinirole—Anaemia—Methotrexate—testicular cancer	0.000263	0.000263	CcSEcCtD
Ropinirole—Flushing—Doxorubicin—testicular cancer	0.000263	0.000263	CcSEcCtD
Ropinirole—Cardiac disorder—Doxorubicin—testicular cancer	0.000263	0.000263	CcSEcCtD
Ropinirole—Flatulence—Epirubicin—testicular cancer	0.000262	0.000262	CcSEcCtD
Ropinirole—Tension—Epirubicin—testicular cancer	0.000261	0.000261	CcSEcCtD
Ropinirole—Dysgeusia—Epirubicin—testicular cancer	0.000261	0.000261	CcSEcCtD
Ropinirole—Nervousness—Epirubicin—testicular cancer	0.000259	0.000259	CcSEcCtD
Ropinirole—Back pain—Epirubicin—testicular cancer	0.000258	0.000258	CcSEcCtD
Ropinirole—Angiopathy—Doxorubicin—testicular cancer	0.000257	0.000257	CcSEcCtD
Ropinirole—Malaise—Methotrexate—testicular cancer	0.000257	0.000257	CcSEcCtD
Ropinirole—Dizziness—Etoposide—testicular cancer	0.000256	0.000256	CcSEcCtD
Ropinirole—Muscle spasms—Epirubicin—testicular cancer	0.000256	0.000256	CcSEcCtD
Ropinirole—Immune system disorder—Doxorubicin—testicular cancer	0.000256	0.000256	CcSEcCtD
Ropinirole—Vertigo—Methotrexate—testicular cancer	0.000256	0.000256	CcSEcCtD
Ropinirole—Mediastinal disorder—Doxorubicin—testicular cancer	0.000255	0.000255	CcSEcCtD
Ropinirole—Leukopenia—Methotrexate—testicular cancer	0.000255	0.000255	CcSEcCtD
Ropinirole—Chills—Doxorubicin—testicular cancer	0.000254	0.000254	CcSEcCtD
Ropinirole—Arrhythmia—Doxorubicin—testicular cancer	0.000253	0.000253	CcSEcCtD
Ropinirole—Nausea—Cisplatin—testicular cancer	0.000251	0.000251	CcSEcCtD
Ropinirole—Vision blurred—Epirubicin—testicular cancer	0.000251	0.000251	CcSEcCtD
Ropinirole—Alopecia—Doxorubicin—testicular cancer	0.00025	0.00025	CcSEcCtD
Ropinirole—Cough—Methotrexate—testicular cancer	0.000248	0.000248	CcSEcCtD
Ropinirole—Mental disorder—Doxorubicin—testicular cancer	0.000248	0.000248	CcSEcCtD
Ropinirole—Ill-defined disorder—Epirubicin—testicular cancer	0.000247	0.000247	CcSEcCtD
Ropinirole—Convulsion—Methotrexate—testicular cancer	0.000246	0.000246	CcSEcCtD
Ropinirole—Vomiting—Etoposide—testicular cancer	0.000246	0.000246	CcSEcCtD
Ropinirole—Malnutrition—Doxorubicin—testicular cancer	0.000246	0.000246	CcSEcCtD
Ropinirole—Anaemia—Epirubicin—testicular cancer	0.000246	0.000246	CcSEcCtD
Ropinirole—Agitation—Epirubicin—testicular cancer	0.000245	0.000245	CcSEcCtD
Ropinirole—Rash—Etoposide—testicular cancer	0.000244	0.000244	CcSEcCtD
Ropinirole—Dermatitis—Etoposide—testicular cancer	0.000244	0.000244	CcSEcCtD
Ropinirole—Headache—Etoposide—testicular cancer	0.000243	0.000243	CcSEcCtD
Ropinirole—Flatulence—Doxorubicin—testicular cancer	0.000243	0.000243	CcSEcCtD
Ropinirole—Chest pain—Methotrexate—testicular cancer	0.000242	0.000242	CcSEcCtD
Ropinirole—Arthralgia—Methotrexate—testicular cancer	0.000242	0.000242	CcSEcCtD
Ropinirole—Myalgia—Methotrexate—testicular cancer	0.000242	0.000242	CcSEcCtD
Ropinirole—Tension—Doxorubicin—testicular cancer	0.000242	0.000242	CcSEcCtD
Ropinirole—Dysgeusia—Doxorubicin—testicular cancer	0.000241	0.000241	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000241	0.000241	CcSEcCtD
Ropinirole—Malaise—Epirubicin—testicular cancer	0.00024	0.00024	CcSEcCtD
Ropinirole—Discomfort—Methotrexate—testicular cancer	0.000239	0.000239	CcSEcCtD
Ropinirole—Nervousness—Doxorubicin—testicular cancer	0.000239	0.000239	CcSEcCtD
Ropinirole—Vertigo—Epirubicin—testicular cancer	0.000239	0.000239	CcSEcCtD
Ropinirole—Syncope—Epirubicin—testicular cancer	0.000239	0.000239	CcSEcCtD
Ropinirole—Leukopenia—Epirubicin—testicular cancer	0.000238	0.000238	CcSEcCtD
Ropinirole—Back pain—Doxorubicin—testicular cancer	0.000238	0.000238	CcSEcCtD
Ropinirole—Muscle spasms—Doxorubicin—testicular cancer	0.000237	0.000237	CcSEcCtD
Ropinirole—Palpitations—Epirubicin—testicular cancer	0.000235	0.000235	CcSEcCtD
Ropinirole—Confusional state—Methotrexate—testicular cancer	0.000234	0.000234	CcSEcCtD
Ropinirole—Loss of consciousness—Epirubicin—testicular cancer	0.000234	0.000234	CcSEcCtD
Ropinirole—Cough—Epirubicin—testicular cancer	0.000232	0.000232	CcSEcCtD
Ropinirole—Vision blurred—Doxorubicin—testicular cancer	0.000232	0.000232	CcSEcCtD
Ropinirole—Convulsion—Epirubicin—testicular cancer	0.000231	0.000231	CcSEcCtD
Ropinirole—Infection—Methotrexate—testicular cancer	0.000231	0.000231	CcSEcCtD
Ropinirole—Nausea—Etoposide—testicular cancer	0.00023	0.00023	CcSEcCtD
Ropinirole—Hypertension—Epirubicin—testicular cancer	0.00023	0.00023	CcSEcCtD
Ropinirole—Ill-defined disorder—Doxorubicin—testicular cancer	0.000229	0.000229	CcSEcCtD
Ropinirole—Nervous system disorder—Methotrexate—testicular cancer	0.000228	0.000228	CcSEcCtD
Ropinirole—Anaemia—Doxorubicin—testicular cancer	0.000228	0.000228	CcSEcCtD
Ropinirole—Thrombocytopenia—Methotrexate—testicular cancer	0.000227	0.000227	CcSEcCtD
Ropinirole—Chest pain—Epirubicin—testicular cancer	0.000227	0.000227	CcSEcCtD
Ropinirole—Arthralgia—Epirubicin—testicular cancer	0.000227	0.000227	CcSEcCtD
Ropinirole—Myalgia—Epirubicin—testicular cancer	0.000227	0.000227	CcSEcCtD
Ropinirole—Agitation—Doxorubicin—testicular cancer	0.000226	0.000226	CcSEcCtD
Ropinirole—Anxiety—Epirubicin—testicular cancer	0.000226	0.000226	CcSEcCtD
Ropinirole—Skin disorder—Methotrexate—testicular cancer	0.000226	0.000226	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000225	0.000225	CcSEcCtD
Ropinirole—Hyperhidrosis—Methotrexate—testicular cancer	0.000224	0.000224	CcSEcCtD
Ropinirole—Discomfort—Epirubicin—testicular cancer	0.000224	0.000224	CcSEcCtD
Ropinirole—Malaise—Doxorubicin—testicular cancer	0.000222	0.000222	CcSEcCtD
Ropinirole—Dry mouth—Epirubicin—testicular cancer	0.000222	0.000222	CcSEcCtD
Ropinirole—Vertigo—Doxorubicin—testicular cancer	0.000221	0.000221	CcSEcCtD
Ropinirole—Anorexia—Methotrexate—testicular cancer	0.000221	0.000221	CcSEcCtD
Ropinirole—Syncope—Doxorubicin—testicular cancer	0.000221	0.000221	CcSEcCtD
Ropinirole—Leukopenia—Doxorubicin—testicular cancer	0.000221	0.000221	CcSEcCtD
Ropinirole—Confusional state—Epirubicin—testicular cancer	0.000219	0.000219	CcSEcCtD
Ropinirole—Palpitations—Doxorubicin—testicular cancer	0.000218	0.000218	CcSEcCtD
Ropinirole—Oedema—Epirubicin—testicular cancer	0.000217	0.000217	CcSEcCtD
Ropinirole—Hypotension—Methotrexate—testicular cancer	0.000217	0.000217	CcSEcCtD
Ropinirole—Loss of consciousness—Doxorubicin—testicular cancer	0.000217	0.000217	CcSEcCtD
Ropinirole—Infection—Epirubicin—testicular cancer	0.000216	0.000216	CcSEcCtD
Ropinirole—Cough—Doxorubicin—testicular cancer	0.000215	0.000215	CcSEcCtD
Ropinirole—Shock—Epirubicin—testicular cancer	0.000214	0.000214	CcSEcCtD
Ropinirole—Convulsion—Doxorubicin—testicular cancer	0.000213	0.000213	CcSEcCtD
Ropinirole—Nervous system disorder—Epirubicin—testicular cancer	0.000213	0.000213	CcSEcCtD
Ropinirole—Thrombocytopenia—Epirubicin—testicular cancer	0.000213	0.000213	CcSEcCtD
Ropinirole—Hypertension—Doxorubicin—testicular cancer	0.000213	0.000213	CcSEcCtD
Ropinirole—Tachycardia—Epirubicin—testicular cancer	0.000212	0.000212	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000212	0.000212	CcSEcCtD
Ropinirole—Skin disorder—Epirubicin—testicular cancer	0.000211	0.000211	CcSEcCtD
Ropinirole—Hyperhidrosis—Epirubicin—testicular cancer	0.00021	0.00021	CcSEcCtD
Ropinirole—Insomnia—Methotrexate—testicular cancer	0.00021	0.00021	CcSEcCtD
Ropinirole—Chest pain—Doxorubicin—testicular cancer	0.00021	0.00021	CcSEcCtD
Ropinirole—Arthralgia—Doxorubicin—testicular cancer	0.00021	0.00021	CcSEcCtD
Ropinirole—Myalgia—Doxorubicin—testicular cancer	0.00021	0.00021	CcSEcCtD
Ropinirole—Anxiety—Doxorubicin—testicular cancer	0.000209	0.000209	CcSEcCtD
Ropinirole—Paraesthesia—Methotrexate—testicular cancer	0.000208	0.000208	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000208	0.000208	CcSEcCtD
Ropinirole—Discomfort—Doxorubicin—testicular cancer	0.000207	0.000207	CcSEcCtD
Ropinirole—Anorexia—Epirubicin—testicular cancer	0.000207	0.000207	CcSEcCtD
Ropinirole—Dyspnoea—Methotrexate—testicular cancer	0.000207	0.000207	CcSEcCtD
Ropinirole—Somnolence—Methotrexate—testicular cancer	0.000206	0.000206	CcSEcCtD
Ropinirole—Dry mouth—Doxorubicin—testicular cancer	0.000205	0.000205	CcSEcCtD
Ropinirole—Dyspepsia—Methotrexate—testicular cancer	0.000204	0.000204	CcSEcCtD
Ropinirole—Hypotension—Epirubicin—testicular cancer	0.000203	0.000203	CcSEcCtD
Ropinirole—Confusional state—Doxorubicin—testicular cancer	0.000203	0.000203	CcSEcCtD
Ropinirole—Decreased appetite—Methotrexate—testicular cancer	0.000202	0.000202	CcSEcCtD
Ropinirole—Oedema—Doxorubicin—testicular cancer	0.000201	0.000201	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Methotrexate—testicular cancer	0.0002	0.0002	CcSEcCtD
Ropinirole—Fatigue—Methotrexate—testicular cancer	0.0002	0.0002	CcSEcCtD
Ropinirole—Infection—Doxorubicin—testicular cancer	0.0002	0.0002	CcSEcCtD
Ropinirole—Pain—Methotrexate—testicular cancer	0.000199	0.000199	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000198	0.000198	CcSEcCtD
Ropinirole—Shock—Doxorubicin—testicular cancer	0.000198	0.000198	CcSEcCtD
Ropinirole—Nervous system disorder—Doxorubicin—testicular cancer	0.000197	0.000197	CcSEcCtD
Ropinirole—Thrombocytopenia—Doxorubicin—testicular cancer	0.000197	0.000197	CcSEcCtD
Ropinirole—Insomnia—Epirubicin—testicular cancer	0.000197	0.000197	CcSEcCtD
Ropinirole—Tachycardia—Doxorubicin—testicular cancer	0.000196	0.000196	CcSEcCtD
Ropinirole—Skin disorder—Doxorubicin—testicular cancer	0.000195	0.000195	CcSEcCtD
Ropinirole—Paraesthesia—Epirubicin—testicular cancer	0.000195	0.000195	CcSEcCtD
Ropinirole—Hyperhidrosis—Doxorubicin—testicular cancer	0.000194	0.000194	CcSEcCtD
Ropinirole—Dyspnoea—Epirubicin—testicular cancer	0.000194	0.000194	CcSEcCtD
Ropinirole—Somnolence—Epirubicin—testicular cancer	0.000193	0.000193	CcSEcCtD
Ropinirole—Anorexia—Doxorubicin—testicular cancer	0.000192	0.000192	CcSEcCtD
Ropinirole—Feeling abnormal—Methotrexate—testicular cancer	0.000191	0.000191	CcSEcCtD
Ropinirole—Dyspepsia—Epirubicin—testicular cancer	0.000191	0.000191	CcSEcCtD
Ropinirole—Gastrointestinal pain—Methotrexate—testicular cancer	0.00019	0.00019	CcSEcCtD
Ropinirole—Decreased appetite—Epirubicin—testicular cancer	0.000189	0.000189	CcSEcCtD
Ropinirole—Hypotension—Doxorubicin—testicular cancer	0.000188	0.000188	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000188	0.000188	CcSEcCtD
Ropinirole—Fatigue—Epirubicin—testicular cancer	0.000187	0.000187	CcSEcCtD
Ropinirole—Pain—Epirubicin—testicular cancer	0.000186	0.000186	CcSEcCtD
Ropinirole—Constipation—Epirubicin—testicular cancer	0.000186	0.000186	CcSEcCtD
Ropinirole—Urticaria—Methotrexate—testicular cancer	0.000184	0.000184	CcSEcCtD
Ropinirole—Abdominal pain—Methotrexate—testicular cancer	0.000184	0.000184	CcSEcCtD
Ropinirole—Body temperature increased—Methotrexate—testicular cancer	0.000184	0.000184	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000183	0.000183	CcSEcCtD
Ropinirole—Insomnia—Doxorubicin—testicular cancer	0.000182	0.000182	CcSEcCtD
Ropinirole—Paraesthesia—Doxorubicin—testicular cancer	0.000181	0.000181	CcSEcCtD
Ropinirole—Dyspnoea—Doxorubicin—testicular cancer	0.000179	0.000179	CcSEcCtD
Ropinirole—Feeling abnormal—Epirubicin—testicular cancer	0.000179	0.000179	CcSEcCtD
Ropinirole—Somnolence—Doxorubicin—testicular cancer	0.000179	0.000179	CcSEcCtD
Ropinirole—Gastrointestinal pain—Epirubicin—testicular cancer	0.000178	0.000178	CcSEcCtD
Ropinirole—Dyspepsia—Doxorubicin—testicular cancer	0.000177	0.000177	CcSEcCtD
Ropinirole—Decreased appetite—Doxorubicin—testicular cancer	0.000175	0.000175	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000174	0.000174	CcSEcCtD
Ropinirole—Fatigue—Doxorubicin—testicular cancer	0.000173	0.000173	CcSEcCtD
Ropinirole—Urticaria—Epirubicin—testicular cancer	0.000173	0.000173	CcSEcCtD
Ropinirole—Pain—Doxorubicin—testicular cancer	0.000172	0.000172	CcSEcCtD
Ropinirole—Constipation—Doxorubicin—testicular cancer	0.000172	0.000172	CcSEcCtD
Ropinirole—Abdominal pain—Epirubicin—testicular cancer	0.000172	0.000172	CcSEcCtD
Ropinirole—Body temperature increased—Epirubicin—testicular cancer	0.000172	0.000172	CcSEcCtD
Ropinirole—Hypersensitivity—Methotrexate—testicular cancer	0.000171	0.000171	CcSEcCtD
Ropinirole—Asthenia—Methotrexate—testicular cancer	0.000167	0.000167	CcSEcCtD
Ropinirole—Feeling abnormal—Doxorubicin—testicular cancer	0.000166	0.000166	CcSEcCtD
Ropinirole—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000164	0.000164	CcSEcCtD
Ropinirole—Pruritus—Methotrexate—testicular cancer	0.000164	0.000164	CcSEcCtD
Ropinirole—Hypersensitivity—Epirubicin—testicular cancer	0.00016	0.00016	CcSEcCtD
Ropinirole—Urticaria—Doxorubicin—testicular cancer	0.00016	0.00016	CcSEcCtD
Ropinirole—Body temperature increased—Doxorubicin—testicular cancer	0.000159	0.000159	CcSEcCtD
Ropinirole—Abdominal pain—Doxorubicin—testicular cancer	0.000159	0.000159	CcSEcCtD
Ropinirole—Diarrhoea—Methotrexate—testicular cancer	0.000159	0.000159	CcSEcCtD
Ropinirole—Asthenia—Epirubicin—testicular cancer	0.000156	0.000156	CcSEcCtD
Ropinirole—Pruritus—Epirubicin—testicular cancer	0.000154	0.000154	CcSEcCtD
Ropinirole—Dizziness—Methotrexate—testicular cancer	0.000154	0.000154	CcSEcCtD
Ropinirole—Diarrhoea—Epirubicin—testicular cancer	0.000149	0.000149	CcSEcCtD
Ropinirole—Hypersensitivity—Doxorubicin—testicular cancer	0.000148	0.000148	CcSEcCtD
Ropinirole—Vomiting—Methotrexate—testicular cancer	0.000148	0.000148	CcSEcCtD
Ropinirole—Rash—Methotrexate—testicular cancer	0.000146	0.000146	CcSEcCtD
Ropinirole—Dermatitis—Methotrexate—testicular cancer	0.000146	0.000146	CcSEcCtD
Ropinirole—Headache—Methotrexate—testicular cancer	0.000145	0.000145	CcSEcCtD
Ropinirole—Asthenia—Doxorubicin—testicular cancer	0.000144	0.000144	CcSEcCtD
Ropinirole—Dizziness—Epirubicin—testicular cancer	0.000144	0.000144	CcSEcCtD
Ropinirole—Pruritus—Doxorubicin—testicular cancer	0.000142	0.000142	CcSEcCtD
Ropinirole—Vomiting—Epirubicin—testicular cancer	0.000138	0.000138	CcSEcCtD
Ropinirole—Nausea—Methotrexate—testicular cancer	0.000138	0.000138	CcSEcCtD
Ropinirole—Diarrhoea—Doxorubicin—testicular cancer	0.000138	0.000138	CcSEcCtD
Ropinirole—Rash—Epirubicin—testicular cancer	0.000137	0.000137	CcSEcCtD
Ropinirole—Dermatitis—Epirubicin—testicular cancer	0.000137	0.000137	CcSEcCtD
Ropinirole—Headache—Epirubicin—testicular cancer	0.000136	0.000136	CcSEcCtD
Ropinirole—Dizziness—Doxorubicin—testicular cancer	0.000133	0.000133	CcSEcCtD
Ropinirole—Nausea—Epirubicin—testicular cancer	0.000129	0.000129	CcSEcCtD
Ropinirole—Vomiting—Doxorubicin—testicular cancer	0.000128	0.000128	CcSEcCtD
Ropinirole—Rash—Doxorubicin—testicular cancer	0.000127	0.000127	CcSEcCtD
Ropinirole—Dermatitis—Doxorubicin—testicular cancer	0.000127	0.000127	CcSEcCtD
Ropinirole—Headache—Doxorubicin—testicular cancer	0.000126	0.000126	CcSEcCtD
Ropinirole—Nausea—Doxorubicin—testicular cancer	0.000119	0.000119	CcSEcCtD
